These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32723981)

  • 1. Lymphoid Enhancer Binding Factor 1 (LEF1) and Paired Box Gene 8 (PAX8): A Limited Immunohistochemistry Panel to Distinguish Solid Pseudopapillary Neoplasms and Pancreatic Neuroendocrine Tumors.
    Lu H; Allende D; Liu X; Zhang Y
    Appl Immunohistochem Mol Morphol; 2020; 28(10):776-780. PubMed ID: 32723981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness of lymphoid enhancer-binding factor 1 and androgen receptor in diagnosing solid pseudopapillary neoplasm of the pancreas on cytopathology.
    McHugh KE; Stelow EB; Harrison GP; Policarpio-Nicolas MLC
    Cancer Cytopathol; 2019 Nov; 127(11):700-707. PubMed ID: 31584754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic Utility of LEF1 Immunostain in Cytology Specimens of Solid Pseudopapillary Neoplasm of Pancreas].
    Farzaneh T; Nowroozizadeh B; Han M; Lee W
    Acta Cytol; 2021; 65(3):250-256. PubMed ID: 33887729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of SOX11 for the diagnosis of solid pseudopapillary neoplasm of the pancreas on cytological preparations.
    Dinarvand P; Wang WL; Roy-Chowdhuri S
    Cytopathology; 2022 Mar; 33(2):216-221. PubMed ID: 34816516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A limited panel of INSM1 and LEF1 immunostains accurately distinguishes between pancreatic neuroendocrine tumor and solid pseudopapillary neoplasm.
    Guo W; Farzaneh T; Lee W; Nael A; Li X; Chandan VS
    Pathol Res Pract; 2021 Jul; 223():153462. PubMed ID: 34048981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid-pseudopapillary neoplasm of the pancreas: awareness of unusual clinical presentations and morphology of the clear cell variant can prevent diagnostic errors.
    Zhao P; deBrito P; Ozdemirli M; Sidawy MK
    Diagn Cytopathol; 2013 Oct; 41(10):889-95. PubMed ID: 23584981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of lymphoid enhancer-binding factor 1 (LEF1) in solid-pseudopapillary neoplasms of the pancreas.
    Singhi AD; Lilo M; Hruban RH; Cressman KL; Fuhrer K; Seethala RR
    Mod Pathol; 2014 Oct; 27(10):1355-63. PubMed ID: 24658583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of cytomorphology in distinguishing solid pseudopapillary neoplasm of pancreas from pancreatic neuroendocrine tumor with emphasis on nuclear folds and nuclear grooves.
    Misra S; Saran RK; Srivastava S; Barman S; Dahale A
    Diagn Cytopathol; 2019 Jun; 47(6):531-540. PubMed ID: 30677247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from ileal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma.
    Sangoi AR; Ohgami RS; Pai RK; Beck AH; McKenney JK; Pai RK
    Mod Pathol; 2011 Mar; 24(3):412-24. PubMed ID: 20890270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paired box gene 8, HBME-1, and cytokeratin 19 expression in preoperative fine-needle aspiration of papillary thyroid carcinoma: diagnostic utility.
    Schmitt AC; Cohen C; Siddiqui MT
    Cancer Cytopathol; 2010 Aug; 118(4):196-202. PubMed ID: 20731005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of P504s in distinction between solid pseudopapillary tumor of pancreas and pancreatic neuroendocrine tumors].
    Chen Z; Shi H; Ying L; Zhai X; Fu X; Liu Q; Lou S
    Zhonghua Bing Li Xue Za Zhi; 2015 May; 44(5):320-2. PubMed ID: 26178213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of potential biomarkers to differentially diagnose solid pseudopapillary tumors and pancreatic malignancies via a gene regulatory network.
    Li P; Hu Y; Yi J; Li J; Yang J; Wang J
    J Transl Med; 2015 Nov; 13():361. PubMed ID: 26578390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemistry for SOX-11 and TFE3 as diagnostic markers for solid pseudopapillary neoplasms of the pancreas in FNA biopsies.
    Foo WC; Harrison G; Zhang X
    Cancer Cytopathol; 2017 Nov; 125(11):831-837. PubMed ID: 29045075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-cadherin/beta-catenin and CD10: a limited immunohistochemical panel to distinguish pancreatic endocrine neoplasm from solid pseudopapillary neoplasm of the pancreas on endoscopic ultrasound-guided fine-needle aspirates of the pancreas.
    Burford H; Baloch Z; Liu X; Jhala D; Siegal GP; Jhala N
    Am J Clin Pathol; 2009 Dec; 132(6):831-9. PubMed ID: 19926573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LEF1, TFE3, and AR are putative diagnostic markers of solid pseudopapillary neoplasms.
    Kim EK; Jang M; Park M; Kim H
    Oncotarget; 2017 Nov; 8(55):93404-93413. PubMed ID: 29212159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAX8 is expressed in pancreatic well-differentiated neuroendocrine tumors and in extrapancreatic poorly differentiated neuroendocrine carcinomas in fine-needle aspiration biopsy specimens.
    Haynes CM; Sangoi AR; Pai RK
    Cancer Cytopathol; 2011 Jun; 119(3):193-201. PubMed ID: 21328566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas.
    Jiang Y; Xie J; Wang B; Mu Y; Liu P
    Hum Pathol; 2018 Nov; 81():166-175. PubMed ID: 30030118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EUS-guided FNA cytology of pancreatic neuroendocrine tumour (PanNET): a retrospective study of 132 cases over an 18-year period in a single institution.
    Chen S; Lin J; Wang X; Wu HH; Cramer H
    Cytopathology; 2014 Dec; 25(6):396-403. PubMed ID: 24635775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dilemma of "indeterminate" interpretations of pancreatic neuroendocrine tumors on fine needle aspiration.
    Ahmed A; VandenBussche CJ; Ali SZ; Olson MT
    Diagn Cytopathol; 2016 Jan; 44(1):10-3. PubMed ID: 26402138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaline globules in neuroendocrine and solid-pseudopapillary neoplasms of the pancreas: a clue to the diagnosis.
    Meriden Z; Shi C; Edil BH; Ellison T; Wolfgang CL; Cornish TC; Schulick RD; Hruban RH
    Am J Surg Pathol; 2011 Jul; 35(7):981-8. PubMed ID: 21677537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.